Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 6Active not recruiting 5Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 5Tongue Neoplasms 4Head and Neck Neoplasms 4Prostatic Neoplasms 3Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Squamous Cell 1Mucositis 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Glioma 1Glioblastoma 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Paclitaxel 5Radiotherapy 3Fluorouracil 3Carboplatin 3nimotuzumab 2Taxes 2S 1 (combination) 2Radiation 2Oxaliplatin 2Nivolumab 2Ferrosoferric Oxide 2Drug Therapy 2Cisplatin 2Cetuximab 2pembrolizumab 1entinostat 1atezolizumab 1apatinib 1Watchful Waiting 1Trastuzumab 1TH 302 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Proton Therapy 1Polymerase Chain Reaction 1Observation 1Nimodipine 1Magnetic Resonance Spectroscopy 1Lubricant Eye Drops 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Esophageal Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT03991104 2023-09-21

SOX-based CRT for Esophageal Cancer.

Zhejiang Provincial People's Hospital

Phase 1/2 Withdrawn
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡